Eluminex Biosciences is a health care startup founded in 2020 with a mission to address unmet medical needs in ocular health. The company's slogan "Innovating breakthrough therapies for unmet medical needs in ocular health" underscores its commitment to innovation. Eluminex Biosciences focuses on researching and commercializing novel therapies for the diagnosis, treatment, and control of ocular illnesses.
The latest milestone for Eluminex Biosciences is its $10.00M Series B investment on 18 August 2023, with funding from 元禾辰坤 and Suxin Venture Capital. This investment signifies a significant show of support and confidence from notable venture capital firms, indicating the potential and promise perceived in Eluminex Biosciences' advancements in ocular health solutions within the health and wellness industries.
No recent news or press coverage available for Eluminex Biosciences.